ReShape Lifesciences Inc (NASDAQ:RSLS) has a beta value of 1.60 and has seen 244.39 million shares traded in the last trading session. The company, currently valued at $5.25M, closed the last trade at $1.59 per share which meant it gained $1.23 on the day or 341.05% during that session. The RSLS stock price is -1723.9% off its 52-week high price of $29.00 and 78.62% above the 52-week low of $0.34. If we look at the company’s 10-day average daily trading volume, we find that it stood at 25.8 million shares traded. The 3-month trading volume is 1.23 million shares.
The consensus among analysts is that ReShape Lifesciences Inc (RSLS) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
ReShape Lifesciences Inc (NASDAQ:RSLS) trade information
Sporting 341.05% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the RSLS stock price touched $1.59 or saw a rise of 47.87%. Year-to-date, ReShape Lifesciences Inc shares have moved -64.35%, while the 5-day performance has seen it change 204.07%. Over the past 30 days, the shares of ReShape Lifesciences Inc (NASDAQ:RSLS) have changed 45.87%. Short interest in the company has seen 0.37 million shares shorted with days to cover at 0.11.
ReShape Lifesciences Inc (RSLS) estimates and forecasts
The company’s shares have lost -71.96% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 76.96% over the past 5 years.
RSLS Dividends
ReShape Lifesciences Inc is expected to release its next earnings report on 2024-Nov-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
ReShape Lifesciences Inc (NASDAQ:RSLS)’s Major holders
Insiders own 14.01% of the company shares, while shares held by institutions stand at 16.64% with a share float percentage of 19.35%. Investors are also buoyed by the number of investors in a company, with ReShape Lifesciences Inc having a total of 13.0 institutions that hold shares in the company.
